1. Implications of a Negative Sentinel Node on Radiation Field Design for Chest Wall Recurrences

   • Bruce G. Haffty

   Breast Oncology 17 November 2015 Pages: 703 - 705

2. Lobular Neoplasia: Another Reset in Management?

   • Julie Dunderdale
   • Seema Ahsan Khan

   Editorial 16 December 2015 Pages: 706 - 707

3. Oncologists’ Perspectives of Their Roles and Responsibilities During Multi-disciplinary Breast Cancer Follow-Up

   • Heather B. Neuman
   • Nicole M. Steffens
   • Caprice C. Greenberg

   Healthcare Policy and Outcomes 16 October 2015 Pages: 708 - 714

4. Sentinel Lymph Node Mapping in Post-Mastectomy Chest Wall Recurrences: Influence on Radiation Treatment Fields and Outcome

   • Julian Johnson
   • Laura Esserman
   • Barbara Fowble

   Breast Oncology 29 December 2015 Pages: 715 - 721

   

5. Incidence of Adjacent Synchronous Invasive Carcinoma and/or Ductal Carcinoma In-situ in Patients with Lobular Neoplasia on Core Biopsy: Results from a Prospective Multi-Institutional Registry (TBCRC 020)

   • Faina Nakhlis
   • Lauren Gilmore
   • Tari A. King

   Breast Oncology 05 November 2015 Pages: 722 - 728

   

6. Implications of New Lumpectomy Margin Guidelines for Breast-Conserving Surgery: Changes in Reexcision Rates and Predicted Rates of Residual Tumor

   • Andrea L. Merrill
   • Suzanne B. Coopey
   • Barbara L. Smith

   Breast Oncology 14 October 2015 Pages: 729 - 734

   

7. The Effects of Surgery Type and Chemotherapy on Early-Stage Breast Cancer Patients’ Quality of Life Over 2-Year Follow-up

   • Donna B. Jeffe
   • Maria Pérez
   • Mario Schootman

   Breast Oncology 28 October 2015 Pages: 735 - 743

   

8. Reoperative Sentinel Lymph Node Biopsy is Feasible for Locally Recurrent Breast Cancer, But is it Worthwhile?

   • Stacy Ugras
   • Cindy Matsen
   • Hiram S. Cody III

   Breast Oncology 07 December 2015 Pages: 744 - 748

   

9. Locoregional Control According to Breast Cancer Subtype and Response to Neoadjuvant Chemotherapy in Breast Cancer Patients Undergoing Breast-conserving Therapy

   • Shannon K. Swisher
   • Jose Vila
   • Elizabeth A. Mittendorf

   Breast Oncology 28 October 2015 Pages: 749 - 756

   

10. Disseminated Tumor Cells in the Bone Marrow of Patients with Operable Primary Breast Cancer: Prognostic Impact in Immunophenotypic Subgroups and Clinical Implication for Bisphosphonate Treatment

    • Stefan Stefanovic
    • Ingo Diel
    • Christoph Domschke

    Breast Oncology 14 October 2015 Pages: 757 - 766

    

11. Occult Histopathology and Its Predictors in Contralateral and Bilateral Prophylactic Mastectomies

    • David Mattos
    • Lisa Gfrerer
    • Eric C. Liao

    Breast Oncology 17 November 2015 Pages: 767 - 775

12. Evaluation of Oncological Safety of Fat Grafting After Breast-Conserving Therapy: A Prospective Study

    • Ondrej Mestak
    • Veronika Hromadkova
    • Jan Mestak

    Breast Oncology 14 October 2015 Pages: 776 - 781

    

13. Does Mammographic Density have an Impact on the Margin Re-excision Rate After Breast-Conserving Surgery?

    • Brandy L. Edwards
    • Christopher A. Guidry
    • Anneke T. Schroen

    Breast Oncology 15 October 2015 Pages: 782 - 788

14. Can Routine Imaging After Neoadjuvant Chemotherapy in Breast Cancer Predict Pathologic Complete Response?

    • B. Schaefgen
    • M. Mati
    • Joerg Heil

    Breast Oncology 14 October 2015 Pages: 789 - 795

15. A Novel Light-Emitting Wire Enhances the Marking and Visualization of Pathologic Mammary Ducts During Selective Microdochectomy

    • Xiao-Peng Ma
    • Wei Wang
    • Fu-Sheng Den

    Breast Oncology 28 October 2015 Pages: 796 - 800

    

16. Complications and Postoperative Mortality Rate After Surgery for Pathological Femur Fracture Related to Bone Metastasis: Analysis of a Nationwide Database

    • Yusuke Tsuda
    • Hideo Yasunaga
    • Sakae Tanaka

    Bone and Soft Tissue Sarcomas 05 October 2015 Pages: 801 - 810

17. Prognosis of Primary and Recurrent Chondrosarcoma of the Rib

    • Eva Roos
    • Frits van Coevorden
    • Winan J. van Houdt

    Bone and Soft Tissue Sarcomas 23 October 2015 Pages: 811 - 817

    

18. Optimal Percent Myxoid Component to Predict Outcome in High-Grade Myxofibrosarcoma and Undifferentiated Pleomorphic Sarcoma

    • Ann Y. Lee
    • Narasimhan P. Agaram
    • Samuel Singer

    Bone and Soft Tissue Sarcomas 12 January 2016 Pages: 818 - 825

    

19. A Novel Immune Marker Model Predicts Oncological Outcomes of Patients with Colorectal Cancer

    • Yufeng Chen
    • Ruixue Yuan
    • Xiaojian Wu

    Colorectal Cancer 18 November 2015 Pages: 826 - 832

    

20. Predictors of Severe Morbidity After Cytoreductive Surgery and Hyperthermic Intraperitoneal Chemotherapy for Patients With Colorectal Peritoneal Carcinomatosis

    • Geert A. Simkens
    • Thijs R. van Oudheusden
    • Ignace H. de Hingh

    Colorectal Cancer 06 October 2015 Pages: 833 - 841

    

21. Stenting as a Bridge to Surgery for Obstructive Colon Cancer: Does It Have Surgical Merit or Oncologic Demerit?

    • Sun Jin Park
    • Kil Yeon Lee
    • Suk-Hwan Lee

    Colorectal Cancer 14 December 2015 Pages: 842 - 848

    

22. Mutation Spectra of Common Cancer-Associated Genes in Different Phenotypes of Colorectal Carcinoma Without Distant Metastasis

    • Shih-Ching Chang
    • Pei-Ching Lin
    • Jeng-Kai Jiang

    Colorectal Cancer 15 October 2015 Pages: 849 - 855

    

23. Role of Adjuvant Radiotherapy in Locally Advanced Colonic Carcinoma in the Modern Chemotherapy Era

    • Ethan B. Ludmir
    • Ritu Arya
    • Brian G. Czito

    Colorectal Cancer 19 October 2015 Pages: 856 - 862

    

24. Early Postoperative Chemotherapy After Complete Cytoreduction and Hyperthermic Intraperitoneal Chemotherapy for Isolated Peritoneal Carcinomatosis of Colon Cancer: A Multicenter Study

    • Marianne Maillet
    • Olivier Glehen
    • BIG-RENAPE Working Group

    Colorectal Cancer 19 October 2015 Pages: 863 - 869

    

25. Prognosis of Ulcerative Colitis-Associated Colorectal Carcinoma Compared to Sporadic Colorectal Carcinoma: A Matched Pair Analysis

    • Christine Leowardi
    • Marie-Luise Schneider
    • Martina Kadmon

    Colorectal Cancer 14 October 2015 Pages: 870 - 876

    

26. Optimal Timing of Surgical Resection After Radiation in Locally Advanced Rectal Adenocarcinoma: An Analysis of the National Cancer Database

    • Ciara R. Huntington
    • Danielle Boselli
    • Jonathan C. Salo

    Colorectal Cancer 29 October 2015 Pages: 877 - 887

    

27. Distant Metastasis in Colorectal Cancer is a Risk Factor for Anastomotic Leakage

    • Samuel A. Käser
    • Diana Mattiello
    • Christoph A. Maurer

    Colorectal Cancer 13 November 2015 Pages: 888 - 893

    

28. Pilot Study of Neoadjuvant Chemoradiotherapy with Three Cycles of 5-Fluorouracil Plus Leucovorin for Treatment of Locally Advanced Rectal Cancer

    • Soo Jung Lee
    • Byung Woog Kang
    • Jong Gwang Kim

    Colorectal Cancer 29 December 2015 Pages: 894 - 899

    

29. Clinical Significance of the C-Reactive Protein to Albumin Ratio for Survival After Surgery for Colorectal Cancer

    • Mitsuru Ishizuka
    • Hitoshi Nagata
    • Keiichi Kubota

    Colorectal Cancer 03 November 2015 Pages: 900 - 907

    

30. Survival Benefit of Exercise Differs by Tumor IRS1 Expression Status in Colorectal Cancer

    • Akiko Hanyuda
    • Sun A. Kim
    • Shuji Ogino

    Colorectal Cancer 17 November 2015 Pages: 908 - 917

    

31. Pushing the Limits of Local Excision for Rectal Cancer: Transanal Minimally Invasive Surgery (TAMIS) for Rectal Cancer Using the Port-in-Port Technique

    • Celia Robinson
    • Avo Artinyan

    Original Article – Colorectal Cancer 07 December 2015 Pages: 918 - 918

32. A High RORγT/CD3 Ratio is a Strong Prognostic Factor for Postoperative Survival in Advanced Colorectal Cancer: Analysis of Helper T Cell Lymphocytes (Th1, Th2, Th17 and Regulatory T Cells)

    • Naohiro Yoshida
    • Tetsushi Kinugasa
    • Koichi Ohshima

    Colorectal Cancer 12 November 2015 Pages: 919 - 927

    

33. Benefit of Adjuvant Chemotherapy After Curative Resection of Lung Metastasis in Colorectal Cancer

    • Hyung Soon Park
    • Minkyu Jung
    • Joong Bae Ahn

    Thoracic Oncology 29 October 2015 Pages: 928 - 935

    

34. CXCL10 Expression Status is Prognostic in Patients with Advanced Thoracic Esophageal Squamous Cell Carcinoma

    • Yusuke Sato
    • Satoru Motoyama
    • Yoshihiro Minamiya

    Gastrointestinal Oncology 13 October 2015 Pages: 936 - 942

    

35. Strong Prognostic Value of Microsatellite Instability in Intestinal Type Non-cardia Gastric Cancer

    • Daniele Marrelli
    • Karol Polom
    • Franco Roviello

    Gastrointestinal Oncology 03 November 2015 Pages: 943 - 950

    

36. Laparoscopic Infrapyloric Area Lymph Node Dissection with No. 14v Enlargement for Advanced Lower Gastric Cancer in Middle Colic Vein Approach

    • Qi-Yue Chen
    • Chang-Ming Huang
    • Xin-Tao Yang

    Gastrointestinal Oncology 29 December 2015 Pages: 951 - 951

37. Single-Port Extra- and Transperitoneal Approach for Paraaortic Lymphadenectomy in Gynecologic Cancers: A Propensity-Adjusted Analysis

    • Clémentine Beytout
    • Enora Laas
    • Emile Daraï

    Gynecologic Oncology 05 October 2015 Pages: 952 - 958

38. Tumor Characteristics and Survival Outcome of Endometrial Cancer Arising in Adenomyosis: An Exploratory Analysis

    • Koji Matsuo
    • Aida Moeini
    • Lynda D. Roman

    Gynecologic Oncology 05 November 2015 Pages: 959 - 967

    

39. Association Between Preoperative Chemotherapy and Postoperative Complications in Patients Undergoing Surgery for Ovarian Cancer

    • David W. Doo
    • Michael S. Guy
    • Saketh R. Guntupalli

    Gynecologic Oncology 05 November 2015 Pages: 968 - 974

40. Predictive Modeling: A New Paradigm for Managing Endometrial Cancer

    • Sofiane Bendifallah
    • Emile Daraï
    • Marcos Ballester

    Gynecologic Oncology 17 November 2015 Pages: 975 - 988

    

41. Is It Time to Centralize Ovarian Cancer Care in the United States?

    • Renee A. Cowan
    • Roisin E. O’Cearbhaill
    • Dennis S. Chi

    Gynecologic Oncology 28 October 2015 Pages: 989 - 993

42. Surgical Resection is Better than Transarterial Chemoembolization for Patients with Hepatocellular Carcinoma Beyond the Milan Criteria: A Prognostic Nomogram Study

    • Chia-Yang Hsu
    • Po-Hong Liu
    • Teh-Ia Huo

    Hepatobiliary Tumors 20 October 2015 Pages: 994 - 1002

    

43. Positive Impact of Epidural Analgesia on Oncologic Outcomes in Patients Undergoing Resection of Colorectal Liver Metastases

    • Giuseppe Zimmitti
    • Jose Soliz
    • Jean-Nicolas Vauthey

    Hepatobiliary Tumors 28 October 2015 Pages: 1003 - 1011

    

44. Predictors and Survival Impact of False-Negative Sentinel Nodes in Melanoma

    • David Y. Lee
    • Kelly T. Huynh
    • Mark B. Faries

    Melanomas 19 November 2015 Pages: 1012 - 1018

    

45. Melanoma Patient-Reported Quality of Life Outcomes Following Sentinel Lymph Node Biopsy, Completion Lymphadenectomy, and Adjuvant Interferon: Results from the Sunbelt Melanoma Trial

    • Michael E. Egger
    • Charles W. Kimbrough
    • Kelly M. McMasters

    Melanomas 07 January 2016 Pages: 1019 - 1025

    

46. Minimally Invasive Pancreaticoduodenectomy Does Not Improve Use or Time to Initiation of Adjuvant Chemotherapy for Patients With Pancreatic Adenocarcinoma

    • Daniel P. Nussbaum
    • Mohamed A. Adam
    • Dan G. Blazer III

    Pancreatic Tumors 05 November 2015 Pages: 1026 - 1033

47. Double Purse-String Telescoped Pancreaticogastro stomy using an Atraumatic Self-retaining Ring Retractor in a Subtotal Stomach-Preserving Pancreaticoduodenectomy

    • Masato Narita
    • Ryo Matsusue
    • Iwao Ikai

    Pancreatic Tumors 05 November 2015 Pages: 1034 - 1034

48. Total Laparoscopic Central Pancreatectomy with Pancreaticogastrostomy for High-Risk Cystic Neoplasm

    • L. Schwarz
    • J. Fleming
    • C. Conrad

    Pancreatic Tumors 05 November 2015 Pages: 1035 - 1035

49. Optimization of Free-Flap Limb Salvage and Maximizing Function and Quality of Life Following Oncologic Resection: 12-Year Experience

    • Edward I. Chang
    • Alexander T. Nguyen
    • Matthew M. Hanasono

    Reconstructive Oncology 14 October 2015 Pages: 1036 - 1043

    

50. High Expression of Colony-Stimulating Factor 1 Receptor Associates with Unfavorable Cancer-Specific Survival of Patients with Clear Cell Renal Cell Carcinoma

    • Liu Yang
    • Yidong Liu
    • Jiejie Xu

    Urologic Oncology 14 October 2015 Pages: 1044 - 1052